|
TWI625121B
(zh)
|
2009-07-13 |
2018-06-01 |
基利科學股份有限公司 |
調節細胞凋亡信號之激酶的抑制劑
|
|
JP5927201B2
(ja)
|
2010-12-16 |
2016-06-01 |
カルチャン リミテッド |
Ａｓｋ１阻害ピロロピリミジン誘導体
|
|
UY34573A
(es)
|
2012-01-27 |
2013-06-28 |
Gilead Sciences Inc |
Inhibidor de la quinasa que regula la señal de la apoptosis
|
|
CA2931615A1
(en)
|
2013-11-26 |
2015-06-04 |
Gilead Sciences, Inc. |
Therapies for treating myeloproliferative disorders
|
|
EP3102238A1
(en)
|
2014-01-20 |
2016-12-14 |
Gilead Sciences, Inc. |
Therapies for treating cancers
|
|
US20150342943A1
(en)
*
|
2014-06-03 |
2015-12-03 |
Gilead Sciences, Inc. |
Methods of treating liver disease
|
|
TW201618781A
(zh)
*
|
2014-08-13 |
2016-06-01 |
吉李德科學股份有限公司 |
治療肺高血壓之方法
|
|
AU2015320792B2
(en)
*
|
2014-09-24 |
2018-08-30 |
Gilead Sciences, Inc. |
Methods of treating liver disease
|
|
JP6439050B2
(ja)
|
2014-12-23 |
2018-12-19 |
ギリアード サイエンシーズ， インコーポレイテッド |
Ａｓｋ１阻害剤を調製するプロセス
|
|
MA41252A
(fr)
|
2014-12-23 |
2017-10-31 |
Gilead Sciences Inc |
Formes solides d'un inhibiteur d'ask 1
|
|
TW201639573A
(zh)
|
2015-02-03 |
2016-11-16 |
吉李德科學股份有限公司 |
有關治療癌症之合併治療
|
|
MY188211A
(en)
|
2015-03-04 |
2021-11-24 |
Gilead Sciences Inc |
Toll-like receptor modulating 4,6-diamino-pyrido[3,2-d]pyrimidine compounds
|
|
US20170008905A1
(en)
|
2015-07-06 |
2017-01-12 |
Gilead Sciences, Inc. |
Cot modulators and methods of use thereof
|
|
JP2018530550A
(ja)
|
2015-10-01 |
2018-10-18 |
ギリアド サイエンシズ， インコーポレイテッド |
癌を治療するためのｂｔｋ阻害剤とチェックポイント阻害剤との組合せ
|
|
CA3000746A1
(en)
*
|
2015-10-02 |
2017-04-06 |
Gilead Sciences, Inc. |
Combinations of the btk inhibitor gs-4059 with inhibitors selected from a jak, ask1, brd and/or mmp9 inhibitor to treat cancer, allergic disorders, autoimmune diseases or inflammatory diseases
|
|
SG11201804294WA
(en)
|
2015-12-17 |
2018-07-30 |
Gilead Sciences Inc |
Tank-binding kinase inhibitor compounds
|
|
CA3016081A1
(en)
|
2016-03-04 |
2017-09-08 |
Gilead Sciences, Inc. |
Compositions and combinations of autotaxin inhibitors
|
|
EP3440113A1
(en)
|
2016-04-08 |
2019-02-13 |
Gilead Sciences, Inc. |
Compositions and methods for treating cancer, inflammatory diseases and autoimmune diseases
|
|
SG11201811003PA
(en)
|
2016-06-13 |
2019-01-30 |
I Mab |
Anti-pd-l1 antibodies and uses thereof
|
|
MA45848A
(fr)
|
2016-08-04 |
2019-06-12 |
Gilead Sciences Inc |
Cobicistat destiné à être utilisé dans des traitements du cancer
|
|
US10640499B2
(en)
|
2016-09-02 |
2020-05-05 |
Gilead Sciences, Inc. |
Toll like receptor modulator compounds
|
|
MA46093A
(fr)
|
2016-09-02 |
2021-05-19 |
Gilead Sciences Inc |
Composés modulateurs du recepteur de type toll
|
|
US20180133212A1
(en)
|
2016-11-03 |
2018-05-17 |
Gilead Sciences, Inc. |
Combination of a bcl-2 inhibitor and a bromodomain inhibitor for treating cancer
|
|
EP3538097A1
(en)
|
2016-11-11 |
2019-09-18 |
Gilead Sciences, Inc. |
Methods of treating liver disease
|
|
US20180141939A1
(en)
|
2016-11-22 |
2018-05-24 |
Gilead Sciences, Inc. |
Solid forms of a bet inhibitor
|
|
AR110252A1
(es)
|
2016-11-30 |
2019-03-13 |
Gilead Sciences Inc |
Compuestos heterocíclicos fusionados como inhibidores de la quinasa cam
|
|
MX376618B
(es)
*
|
2017-01-22 |
2025-03-07 |
Fujian Akeylink Biotechnology Co Ltd |
Derivado de piridina como inhibidor de ask1 y metodo de preparacion y uso del mismo
|
|
WO2018133865A1
(zh)
*
|
2017-01-22 |
2018-07-26 |
福建广生堂药业股份有限公司 |
Ask1抑制剂及其制备方法和应用
|
|
HUE058975T2
(hu)
|
2017-01-24 |
2022-09-28 |
I Mab Biopharma Us Ltd |
CD73-ellenes antitestek és alkalmazásaik
|
|
TWI754011B
(zh)
|
2017-02-24 |
2022-02-01 |
美商基利科學股份有限公司 |
布魯頓氏酪胺酸激酶之抑制劑
|
|
US10314844B2
(en)
|
2017-02-24 |
2019-06-11 |
Gilead Sciences, Inc. |
Inhibitors of Bruton's tyrosine kinase
|
|
WO2018157277A1
(en)
|
2017-02-28 |
2018-09-07 |
Eli Lilly And Company |
Isoquinolin and naphthydrin compounds
|
|
WO2018157856A1
(zh)
*
|
2017-03-03 |
2018-09-07 |
江苏豪森药业集团有限公司 |
酰胺类衍生物抑制剂及其制备方法和应用
|
|
JOP20180017A1
(ar)
|
2017-03-14 |
2019-01-30 |
Gilead Sciences Inc |
مثبط كيناز منظم لإشارة تلاشي خلايا
|
|
JP2020512342A
(ja)
|
2017-03-28 |
2020-04-23 |
ギリアード サイエンシーズ， インコーポレイテッド |
肝疾患を処置する方法
|
|
WO2018191393A1
(en)
|
2017-04-12 |
2018-10-18 |
Gilead Sciences, Inc. |
Methods of treating liver disease
|
|
JOP20180040A1
(ar)
|
2017-04-20 |
2019-01-30 |
Gilead Sciences Inc |
مثبطات pd-1/pd-l1
|
|
PL3621615T3
(pl)
|
2017-05-12 |
2024-03-25 |
Enanta Pharmaceuticals, Inc. |
Inhibitory regulujące sygnał apoptozy kinazy 1 i sposoby ich stosowania
|
|
US10253018B2
(en)
|
2017-05-25 |
2019-04-09 |
Enanta Pharmaceuticals, Inc. |
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
|
|
US10246439B2
(en)
|
2017-05-25 |
2019-04-02 |
Enanta Pharmaceuticals, Inc. |
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
|
|
US10450301B2
(en)
|
2017-05-25 |
2019-10-22 |
Enanta Pharmaceuticals, Inc. |
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
|
|
WO2018231851A1
(en)
|
2017-06-13 |
2018-12-20 |
Gilead Sciences, Inc. |
Methods of treating liver fibrosis
|
|
TW201908306A
(zh)
*
|
2017-07-18 |
2019-03-01 |
大陸商南京聖和藥業股份有限公司 |
作為ask抑制劑的雜環化合物及其應用
|
|
US10597382B2
(en)
|
2017-08-28 |
2020-03-24 |
Enanta Pharmaceuticals, Inc. |
Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
|
|
CN109456308B
(zh)
*
|
2017-09-06 |
2022-11-29 |
南京圣和药业股份有限公司 |
作为ask抑制剂的杂环化合物及其应用
|
|
US10370352B2
(en)
|
2017-09-07 |
2019-08-06 |
Eli Lilly And Company |
Cyclobutyl-imidazolidinone compounds
|
|
WO2019047094A1
(en)
*
|
2017-09-07 |
2019-03-14 |
Eli Lilly And Company |
CYCLOBUTYL-IMIDAZOLIDINONE COMPOUNDS
|
|
WO2019047161A1
(en)
*
|
2017-09-08 |
2019-03-14 |
Eli Lilly And Company |
IMIDAZOLIDINE COMPOUNDS
|
|
JP2020533335A
(ja)
|
2017-09-08 |
2020-11-19 |
フロンセラ ユー．エス． ファーマシューティカルズ エルエルシー |
アポトーシスシグナル調節キナーゼ阻害剤およびその使用
|
|
CN111518080A
(zh)
*
|
2017-10-12 |
2020-08-11 |
深圳市塔吉瑞生物医药有限公司 |
一种1,2,4-三氮唑类化合物
|
|
CN107793400B
(zh)
*
|
2017-10-31 |
2020-01-31 |
武汉九州钰民医药科技有限公司 |
吡啶类化合物及其在制备治疗肝脏疾病的药物中的应用
|
|
ES2986647T3
(es)
|
2017-11-13 |
2024-11-12 |
Gilead Sciences Inc |
Método de estadificación de la fibrosis hepática en pacientes con EHNA
|
|
KR102492115B1
(ko)
|
2017-12-20 |
2023-01-27 |
인스티튜트 오브 오가닉 케미스트리 앤드 바이오케미스트리 에이에스 씨알 브이.브이.아이. |
Sting 어댑터 단백질을 활성화하는 포스포네이트 결합을 가진 2'3' 사이클릭 다이뉴클레오티드
|
|
CA3084569A1
(en)
|
2017-12-20 |
2019-06-27 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
3'3' cyclic dinucleotides with phosphonate bond activating the sting adaptor protein
|
|
CN111801314B
(zh)
|
2018-01-02 |
2023-10-31 |
西尔洛克治疗公司 |
Ask1抑制剂化合物及其用途
|
|
EP4227302A1
(en)
|
2018-02-13 |
2023-08-16 |
Gilead Sciences, Inc. |
Pd-1/pd-l1 inhibitors
|
|
CN110294742B
(zh)
*
|
2018-03-21 |
2023-01-31 |
山东轩竹医药科技有限公司 |
并环类ask1抑制剂及其应用
|
|
TWI818007B
(zh)
|
2018-04-06 |
2023-10-11 |
捷克科學院有機化學與生物化學研究所 |
2'3'-環二核苷酸
|
|
TW202005654A
(zh)
|
2018-04-06 |
2020-02-01 |
捷克科學院有機化學與生物化學研究所 |
２，２，─環二核苷酸
|
|
TWI833744B
(zh)
|
2018-04-06 |
2024-03-01 |
捷克科學院有機化學與生物化學研究所 |
3'3'-環二核苷酸
|
|
EP4537902A3
(en)
*
|
2018-04-12 |
2025-06-11 |
Terns, Inc. |
Tricyclic ask1 inhibitors
|
|
US10899735B2
(en)
|
2018-04-19 |
2021-01-26 |
Gilead Sciences, Inc. |
PD-1/PD-L1 inhibitors
|
|
CN110407806B
(zh)
*
|
2018-04-28 |
2021-08-17 |
深圳微芯生物科技股份有限公司 |
甲酰胺类化合物、其制备方法及其应用
|
|
US10683289B2
(en)
|
2018-05-02 |
2020-06-16 |
Enanta Pharmaceuticals, Inc. |
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
|
|
JP7328254B2
(ja)
|
2018-05-02 |
2023-08-16 |
エナンタ ファーマシューティカルズ インコーポレイテッド |
アポトーシスシグナル調節キナーゼ１阻害剤を含むテトラゾール及びその使用方法
|
|
TW202014193A
(zh)
|
2018-05-03 |
2020-04-16 |
捷克科學院有機化學與生物化學研究所 |
包含碳環核苷酸之2’3’－環二核苷酸
|
|
CA3098873A1
(en)
|
2018-05-11 |
2019-11-14 |
Phosphorex, Inc. |
Microparticles and nanoparticles having negative surface charges
|
|
DK3793565T3
(en)
|
2018-05-14 |
2022-03-07 |
Gilead Sciences Inc |
Mcl-1-inhibitorer
|
|
WO2020006429A1
(en)
*
|
2018-06-28 |
2020-01-02 |
Hepatikos Therapeutics, Llc |
Ask1 isoindolin-1-one inhibitors and methods of use thereof
|
|
UA126421C2
(uk)
|
2018-07-13 |
2022-09-28 |
Гіліад Сайєнсіз, Інк. |
Інгібітори pd-1/pd-l1
|
|
TWI710561B
(zh)
*
|
2018-07-20 |
2020-11-21 |
大陸商福建廣生堂藥業股份有限公司 |
作為ask1抑制劑的晶型及其製備方法和應用
|
|
WO2020041417A1
(en)
|
2018-08-22 |
2020-02-27 |
Enanta Pharmaceuticals, Inc. |
Cycloalkyl-containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
|
|
WO2020072656A1
(en)
|
2018-10-03 |
2020-04-09 |
Gilead Sciences, Inc. |
Imidozopyrimidine derivatives
|
|
KR102298546B1
(ko)
*
|
2018-10-18 |
2021-09-08 |
에이치케이이노엔 주식회사 |
신규한 n-(이소프로필-트리아졸릴)피리디닐)-헤테로아릴-카르복사미드 유도체 및 이의 용도
|
|
AU2019366355B2
(en)
|
2018-10-24 |
2022-10-13 |
Gilead Sciences, Inc. |
PD-1/PD-L1 inhibitors
|
|
WO2020092528A1
(en)
|
2018-10-31 |
2020-05-07 |
Gilead Sciences, Inc. |
Substituted 6-azabenzimidazole compounds having hpk1 inhibitory activity
|
|
HRP20240541T1
(hr)
|
2018-10-31 |
2024-07-05 |
Gilead Sciences, Inc. |
Supstituirani spojevi 6-azabenzimidazola kao inhibitori hpk1
|
|
CN111170995A
(zh)
*
|
2018-11-09 |
2020-05-19 |
山东轩竹医药科技有限公司 |
Ask1抑制剂及其应用
|
|
WO2020106707A1
(en)
|
2018-11-19 |
2020-05-28 |
Enanta Pharmaceuticals, Inc. |
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
|
|
CN109608441A
(zh)
*
|
2018-12-26 |
2019-04-12 |
都创(上海)医药科技有限公司 |
一种ask1抑制剂的合成工艺
|
|
FI3911647T3
(fi)
|
2019-01-15 |
2024-03-01 |
Gilead Sciences Inc |
Isoksatsoliyhdiste fxr-agonistina ja sitä käsittäviä lääkekoostumuksia
|
|
CN109813915A
(zh)
*
|
2019-02-15 |
2019-05-28 |
浠思（上海）生物技术有限公司 |
利用htrf一步法筛选激酶抑制剂的方法
|
|
CA3129949C
(en)
|
2019-02-19 |
2024-04-30 |
Gilead Sciences, Inc. |
Solid forms of fxr agonists
|
|
WO2020178768A1
(en)
|
2019-03-07 |
2020-09-10 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
3'3'-cyclic dinucleotide analogue comprising a cyclopentanyl modified nucleotide as sting modulator
|
|
EP3935066A1
(en)
|
2019-03-07 |
2022-01-12 |
Institute of Organic Chemistry and Biochemistry ASCR, V.V.I. |
3'3'-cyclic dinucleotides and prodrugs thereof
|
|
US12318403B2
(en)
|
2019-03-07 |
2025-06-03 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
2′3′-cyclic dinucleotides and prodrugs thereof
|
|
WO2020185686A1
(en)
|
2019-03-11 |
2020-09-17 |
Gilead Sciences, Inc. |
Formulations of a compound and uses thereof
|
|
WO2020198214A1
(en)
|
2019-03-25 |
2020-10-01 |
Enanta Pharmaceuticals, Inc. |
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
|
|
TW202210480A
(zh)
|
2019-04-17 |
2022-03-16 |
美商基利科學股份有限公司 |
類鐸受體調節劑之固體形式
|
|
TWI751517B
(zh)
|
2019-04-17 |
2022-01-01 |
美商基利科學股份有限公司 |
類鐸受體調節劑之固體形式
|
|
EP3972695A1
(en)
|
2019-05-23 |
2022-03-30 |
Gilead Sciences, Inc. |
Substituted exo-methylene-oxindoles which are hpk1/map4k1 inhibitors
|
|
TW202235416A
(zh)
|
2019-06-14 |
2022-09-16 |
美商基利科學股份有限公司 |
Cot 調節劑及其使用方法
|
|
US20220305115A1
(en)
|
2019-06-18 |
2022-09-29 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and pyridopyrimidine derivatives
|
|
BR112021026376A2
(pt)
|
2019-06-25 |
2022-05-10 |
Gilead Sciences Inc |
Proteínas de fusão flt3l-fc e métodos de uso
|
|
WO2020261294A1
(en)
*
|
2019-06-26 |
2020-12-30 |
Mankind Pharma Ltd. |
Novel apoptosis signal-regulating kinase 1 inhibitors
|
|
AR119594A1
(es)
|
2019-08-09 |
2021-12-29 |
Gilead Sciences Inc |
Derivados de tienopirimidina como inhibidores acc y usos de los mismos
|
|
PL4045083T3
(pl)
|
2019-10-18 |
2024-05-13 |
Forty Seven, Inc. |
Terapie skojarzone do leczenia zespołów mielodysplastycznych i ostrej białaczki szpikowej
|
|
CN114599392A
(zh)
|
2019-10-31 |
2022-06-07 |
四十七公司 |
基于抗cd47和抗cd20的血癌治疗
|
|
TWI778443B
(zh)
|
2019-11-12 |
2022-09-21 |
美商基利科學股份有限公司 |
Mcl1抑制劑
|
|
KR102775995B1
(ko)
|
2019-11-15 |
2025-03-11 |
길리애드 사이언시즈, 인코포레이티드 |
Lpa 수용체 길항제로서의 트라이아졸 카르바메이트 피리딜 설폰아미드 및 이의 용도
|
|
CN111018831B
(zh)
*
|
2019-11-21 |
2022-05-31 |
中国药科大学 |
细胞凋亡信号调节激酶抑制剂及其应用
|
|
US20230105984A1
(en)
|
2019-12-23 |
2023-04-06 |
Svetlana Marukian |
Compositions and methods for the treatment of liver diseases and disorders
|
|
US11845723B2
(en)
|
2019-12-24 |
2023-12-19 |
Gilead Sciences, Inc. |
Diacylglycerol kinase modulating compounds
|
|
CR20220396A
(es)
|
2020-02-14 |
2022-11-14 |
Jounce Therapeutics Inc |
Anticuerpos y proteínas de fusión que se unen a ccr8 y usos de estos
|
|
EP4126231A1
(en)
|
2020-03-30 |
2023-02-08 |
Gilead Sciences, Inc. |
Solid forms of (s)-6-(((1-(bicyclo[1.1.1]pentan-1-yl)-1h-1,2,3-triazol-4-yl)2-methyl-1-oxo-1,2- dihydroisoquinolin-5-yl)methyl)))amino)8-chloro-(neopentylamino)quinoline-3-carb onitrile a cot inhibitor compound
|
|
CN115397824B
(zh)
|
2020-04-02 |
2024-10-22 |
吉利德科学公司 |
用于制备cot抑制剂化合物的方法
|
|
EP4143194A1
(en)
|
2020-05-01 |
2023-03-08 |
Gilead Sciences, Inc. |
Cd73 inhibiting 2,4-dioxopyrimidine compounds
|
|
US11702407B2
(en)
|
2020-06-03 |
2023-07-18 |
Gilead Sciences, Inc. |
LPA receptor antagonists and uses thereof
|
|
CN113831323B
(zh)
*
|
2020-06-24 |
2025-08-29 |
武汉人福创新药物研发中心有限公司 |
芳杂环酰胺类化合物及其用途
|
|
CN111808079A
(zh)
*
|
2020-08-05 |
2020-10-23 |
中国药科大学 |
吲哚类ask1小分子抑制剂及其制备方法和应用
|
|
CN114470217B
(zh)
*
|
2020-11-24 |
2023-06-20 |
深圳微芯生物科技股份有限公司 |
预防和治疗代谢异常或炎症引起的组织损伤的药物组合物
|
|
EP4304711A1
(en)
|
2021-03-11 |
2024-01-17 |
Gilead Sciences, Inc. |
Glp-1r modulating compounds
|
|
CN117120429A
(zh)
|
2021-03-29 |
2023-11-24 |
吉利德科学公司 |
Khk抑制剂
|
|
TW202302145A
(zh)
|
2021-04-14 |
2023-01-16 |
美商基利科學股份有限公司 |
ＣＤ４７／ＳＩＲＰα結合及ＮＥＤＤ８活化酶Ｅ１調節次單元之共抑制以用於治療癌症
|
|
CN114246866B
(zh)
*
|
2021-04-28 |
2023-09-12 |
深圳微芯生物科技股份有限公司 |
用于治疗慢性肾病的药物及其用途
|
|
CN117295717A
(zh)
|
2021-05-11 |
2023-12-26 |
吉利德科学公司 |
Lpa受体拮抗剂及其用途
|
|
CN117295724A
(zh)
|
2021-05-13 |
2023-12-26 |
吉利德科学公司 |
Lpa受体拮抗剂及其用途
|
|
WO2022245671A1
(en)
|
2021-05-18 |
2022-11-24 |
Gilead Sciences, Inc. |
Methods of using flt3l-fc fusion proteins
|
|
TW202304435A
(zh)
|
2021-06-04 |
2023-02-01 |
美商基利科學股份有限公司 |
治療ｎａｓｈ之方法
|
|
TW202311256A
(zh)
|
2021-06-18 |
2023-03-16 |
美商基利科學股份有限公司 |
用於治療ｆｘｒ誘發之搔癢之ｉｌ－３１調節劑
|
|
CN117377671A
(zh)
|
2021-06-23 |
2024-01-09 |
吉利德科学公司 |
二酰基甘油激酶调节化合物
|
|
CA3222277A1
(en)
|
2021-06-23 |
2022-12-29 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
|
AU2022297367B2
(en)
|
2021-06-23 |
2025-04-10 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
|
IL309378A
(en)
|
2021-06-23 |
2024-02-01 |
Gilead Sciences Inc |
Diacylglyercol kinase modulating compounds
|
|
WO2023076983A1
(en)
|
2021-10-28 |
2023-05-04 |
Gilead Sciences, Inc. |
Pyridizin-3(2h)-one derivatives
|
|
PE20241186A1
(es)
|
2021-10-29 |
2024-06-03 |
Gilead Sciences Inc |
Compuestos de cd73
|
|
US20230203202A1
(en)
|
2021-12-08 |
2023-06-29 |
Dragonfly Therapeutics, Inc. |
Proteins binding nkg2d, cd16 and 5t4
|
|
US20230220106A1
(en)
|
2021-12-08 |
2023-07-13 |
Dragonfly Therapeutics, Inc. |
Antibodies targeting 5t4 and uses thereof
|
|
JP7709612B2
(ja)
|
2021-12-08 |
2025-07-16 |
ギリアード サイエンシーズ， インコーポレイテッド |
Ｌｐａ受容体アンタゴニスト及びそれらの使用
|
|
JP2024545193A
(ja)
|
2021-12-22 |
2024-12-05 |
ギリアード サイエンシーズ， インコーポレイテッド |
Ｉｋａｒｏｓジンクフィンガーファミリー分解剤及びその使用
|
|
AU2022419982A1
(en)
|
2021-12-22 |
2024-06-06 |
Gilead Sciences, Inc. |
Ikaros zinc finger family degraders and uses thereof
|
|
TW202340168A
(zh)
|
2022-01-28 |
2023-10-16 |
美商基利科學股份有限公司 |
Ｐａｒｐ７抑制劑
|
|
EP4493554A1
(en)
|
2022-03-17 |
2025-01-22 |
Gilead Sciences, Inc. |
Ikaros zinc finger family degraders and uses thereof
|
|
EP4499146A1
(en)
|
2022-03-24 |
2025-02-05 |
Gilead Sciences, Inc. |
Combination therapy for treating trop-2 expressing cancers
|
|
TWI876305B
(zh)
|
2022-04-05 |
2025-03-11 |
美商基利科學股份有限公司 |
用於治療結腸直腸癌之組合療法
|
|
AU2023256670A1
(en)
|
2022-04-21 |
2024-10-17 |
Gilead Sciences, Inc. |
Kras g12d modulating compounds
|
|
WO2024006929A1
(en)
|
2022-07-01 |
2024-01-04 |
Gilead Sciences, Inc. |
Cd73 compounds
|
|
US20240091351A1
(en)
|
2022-09-21 |
2024-03-21 |
Gilead Sciences, Inc. |
FOCAL IONIZING RADIATION AND CD47/SIRPa DISRUPTION ANTICANCER COMBINATION THERAPY
|
|
AU2023409398A1
(en)
|
2022-12-22 |
2025-06-05 |
Gilead Sciences, Inc. |
Prmt5 inhibitors and uses thereof
|
|
CN115844887B
(zh)
*
|
2022-12-28 |
2023-09-08 |
中国人民解放军空军军医大学 |
Selonsertib在制备治疗癌症的药物中的用途
|
|
WO2024215754A1
(en)
|
2023-04-11 |
2024-10-17 |
Gilead Sciences, Inc. |
Kras modulating compounds
|
|
AU2024259556A1
(en)
|
2023-04-21 |
2025-10-23 |
Gilead Sciences, Inc. |
Prmt5 inhibitors and uses thereof
|
|
WO2024236595A1
(en)
*
|
2023-05-18 |
2024-11-21 |
Council Of Scientific And Industrial Research |
Protacs for ask1 protein degradation: preparation and use thereof
|
|
US20250042922A1
(en)
|
2023-06-30 |
2025-02-06 |
Gilead Sciences, Inc. |
Kras modulating compounds
|
|
WO2025024663A1
(en)
|
2023-07-26 |
2025-01-30 |
Gilead Sciences, Inc. |
Parp7 inhibitors
|
|
TW202519517A
(zh)
|
2023-07-26 |
2025-05-16 |
美商基利科學股份有限公司 |
Ｐａｒｐ７抑制劑
|
|
WO2025054347A1
(en)
|
2023-09-08 |
2025-03-13 |
Gilead Sciences, Inc. |
Kras g12d modulating compounds
|
|
US20250109147A1
(en)
|
2023-09-08 |
2025-04-03 |
Gilead Sciences, Inc. |
Kras g12d modulating compounds
|
|
WO2025096589A1
(en)
|
2023-11-03 |
2025-05-08 |
Gilead Sciences, Inc. |
Prmt5 inhibitors and uses thereof
|
|
WO2025137640A1
(en)
|
2023-12-22 |
2025-06-26 |
Gilead Sciences, Inc. |
Azaspiro wrn inhibitors
|
|
US20250376484A1
(en)
|
2024-05-21 |
2025-12-11 |
Gilead Sciences, Inc. |
Prmt5 inhibitors and uses thereof
|